Table 2.
Considerations for virtual heart failure management
| Continue all current therapy, including renin-angiotensin-aldosterone system blockers |
| Do not delay initiation or up-titration of life-saving therapy. This might be critical for individual patient- and system-level outcomes |
| Fill prescriptions digitally. This might mean a change in practice, but is absolutely necessary to minimize touch points with the health care system |
| Defer imaging studies where feasible and “choose wisely” |
| Look closely at the laboratory tests you order—are they really needed or nice to have? |
| Address and/or update goals of care status for all patients |
| Conduct visits virtually using existing resources and infrastructure. Specifically avoid the default of sending someone to the emergency room if possible |